13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 42 holding rows worth $782,348,000.
- Accession
- 0001144204-16-102679
- Filer
- CIK 1346824
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 42 entries on the cover page, a total value of $782,348,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $782,348,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,088,651 | $98,390,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 12,033,220 | $92,896,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 5,000,000 | $57,400,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,627,719 | $49,795,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 3,178,854 | $43,709,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,161,366 | $40,093,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 4,531,714 | $38,610,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 1,361,582 | $37,089,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,272,048 | $27,006,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 2,451,237 | $22,649,000 | thousands by filing date | |
| ARENA PHARMECEUTICALS INC | 040047102 | COMMON STOCK | 9,364,105 | $18,447,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 2,300,481 | $17,875,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 1,292,940 | $17,532,000 | thousands by filing date | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 1,414,114 | $15,598,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 1,691,977 | $14,923,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 1,174,219 | $14,913,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 2,212,036 | $13,383,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 498,159 | $13,176,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $13,017,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,626,931 | $12,592,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 2,690,702 | $12,270,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 1,548,033 | $12,121,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 3,032,911 | $11,495,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 1,575,000 | $10,442,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 486,557 | $8,831,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,989,795 | $8,461,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 783,520 | $7,459,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 1,045,119 | $7,243,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 1,064,217 | $6,609,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 170,000 | $4,983,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 2,389,700 | $4,899,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 291,700 | $4,892,000 | thousands by filing date | |
| ZYNERBA PHARMACEUTICALS INC | 98986X109 | COM | 507,191 | $4,793,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 604,982 | $4,078,000 | thousands by filing date | |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 236,059 | $3,300,000 | thousands by filing date | |
| ARCA BIOPHARMA INC | 00211Y407 | COM PAR | 778,211 | $2,700,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 257,721 | $2,598,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 612,863 | $2,556,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 144,671 | $2,043,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 56,442 | $1,019,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 81,239 | $252,000 | thousands by filing date | |
| AMPLIPHI BIOSCIENCES ORD SHS | 03211P202 | COM | 53,600 | $211,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-16-102679 | this filing | 2016-05-16 | acceptance time not in the bulk data set |